Tools and resources | CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack | Guidance | NICE

Tools and resources

Tools and resources to help you put the guidance into practice.

Implementation support

UK Centre of Excellence for regulatory science and innovation in pharmacogenomics guideline on CYP2C19 genotype testing for clopidogrel
NHS Pharmacogenomics and Medicines Optimisation Network of Excellence implementation guide
RCGP position statement on CYP2C19 genotyping implementation

Case studies

Laboratory-based CYP2C19 genotype testing to optimise the effectiveness of antiplatelet therapy for patients experiencing acute ischaemic stroke or transient ischaemic attack

Resource impact

Resource impact summary report
Resource impact template (Excel 1 MB)

Published:

31 July 2024

Guidance into practice